Research ExplorerJournalsANN NUCL MED Publications

ANN NUCL MED

1 - 4 out of 4Page size: 50

Publications

  1. 2012

  2. Can (18)F-FDG-PET/CT be generally recommended in patients with differentiated thyroid carcinoma and elevated thyroglobulin levels but negative I-131 whole body scan?

    Bannas, P., Derlin, T., Groth, M., Apostolova, I., Adam, G., Mester, J. & Klutmann, S., 01.2012, In: ANN NUCL MED. 26, 1, p. 77-85 9 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  3. 2011

  4. Quantification of [18F]-FDG uptake in atherosclerotic plaque: impact of renal function

    Derlin, T., Habermann, C. R., Hahne, J. D., Apostolova, I., Klutmann, S., Mester, J. & Buchert, R., 10.2011, In: ANN NUCL MED. 25, 8, p. 586-91 6 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  5. 2010

  6. SPECT/CT stabilizes the interpretation of somatostatin receptor scintigraphy findings: a retrospective analysis of inter-rater agreement.

    Apostolova, I., Riethdorf, S., Buchert, R., Derlin, T., Brenner, W., Mester, J. & Klutmann, S., 2010, In: ANN NUCL MED. 24, 6, p. 477-483 6.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  7. 2009

  8. Impact of additional SPECT in bone scanning in tumor patients with suspected metastatic bone disease.

    Apostolova, I., Gölcük, E., Bohuslavizki, K. H., Buchert, R. & Brenner, W., 2009, In: ANN NUCL MED. 23, 10, p. 869-875 10.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review